Form 8-K - Current report:
SEC Accession No. 0001104659-19-057968
Filing Date
2019-10-31
Accepted
2019-10-30 20:00:01
Documents
8
Period of Report
2019-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-21369_28k.htm 8-K 32723
2 EX-1.1 a19-21369_2ex1d1.htm EX-1.1 300177
3 EX-5.1 a19-21369_2ex5d1.htm EX-5.1 13158
4 EX-99.1 a19-21369_2ex99d1.htm EX-99.1 14805
5 EX-99.2 a19-21369_2ex99d2.htm EX-99.2 14745
6 GRAPHIC g213692moi001.jpg GRAPHIC 3139
7 GRAPHIC g213692mmi001.jpg GRAPHIC 3724
8 GRAPHIC g213692kki001.jpg GRAPHIC 4157
  Complete submission text file 0001104659-19-057968.txt   392324
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 191181609
SIC: 2834 Pharmaceutical Preparations